Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

BioSpecifics Technologies Corp. (BSTC)

66.35   4.04 (6.48%) 07-07 15:59
Open: 65 Pre. Close: 62.31
High: 69.5138 Low: 65
Volume: 84,295 Market Cap: 487M
BioSpecifics Technologies Corp., a biopharmaceutical company, develops an injectable collagenase clostridium histolyticum for various indications in the United States and internationally. The company offers injectable collagenase for the treatment of Dupuytren's contracture and Peyronie's disease under the XIAFLEX and Xiapex brands. It also provides injectable collagenase to treat frozen shoulder, cellulite, canine lipoma, lateral hip fat, plantar fibromatosis, human lipoma, and uterine fibroids. The company has a development and license agreement with Endo Global Ventures. BioSpecifics Technologies Corp. was founded in 1957 and is headquartered in Wilmington, Delaware.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 65.067 - 65.422 65.422 - 65.717
Low: 60.287 - 60.715 60.715 - 61.071
Close: 61.656 - 62.318 62.318 - 62.869

Technical analysis

as of: 2020-07-07 3:32:33 PM
Overall:       
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 81.19     One year: 94.83
Support: Support1: 62.34    Support2: 57.91
Resistance: Resistance1: 69.51    Resistance2: 81.19
Pivot: 61.55
Moving Average: MA(5): 63.03     MA(20): 61.58
MA(100): 57.37     MA(250): 56.49
MACD: MACD(12,26):     Signal(9): 0.75
Stochastic oscillator: %K(14,3): 64.94     %D(3): 64.90
RSI: RSI(14): 62.40
52-week: High: 69.51  Low: 42.00  Change(%): 4.6
Average Vol(K): 3-Month: 3841  10-Days: 4422

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
BSTC has closed above the upper band by 11.8%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 30.1% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Tue, 07 Jul 2020
Timing the Market, Is it Possible? - July 07, 2020 - Yahoo Finance

Tue, 07 Jul 2020
The Daily Biotech Pulse: Novavax Lands $1.6B For COVID-19 Vaccine, Amgen Prevails In Avastin Biosimilar Lawsuit, Cellectis Study Placed On Clinical Hold - Yahoo Finance

Mon, 06 Jul 2020
The Week Ahead In Biotech: Endo, Eagle Pharma FDA Decisions, ObsEva Late-Stage Readouts In Focus - Benzinga

Wed, 01 Jul 2020
Attention Biotech Investors: Mark Your Calendar For These July PDUFA Dates - Benzinga

Fri, 26 Jun 2020
Hedge Funds Souring On BioSpecifics Technologies Corp. (BSTC) - Yahoo Finance

Mon, 22 Jun 2020
BioSpecifics Technologies Corp (BSTC) Soars 2.03% on June 22 - Equities.com

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ Global Market
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 7
Shares Float (M) 5
% Held by Insiders 26.15
% Held by Institutions 66.74
Shares Short (K) 278
Shares Short P. Month (K) 293

Stock Financials

EPS 3.340
EPS Est This Year 1.590
EPS Est Next Year 1.690
Book Value (p.s.) 17.620
Profit Margin 61.80
Operating Margin 74.55
Return on Assets (ttm) 15.5
Return on Equity (ttm) 21.2
Qtrly Rev. Growth 18.9
Gross Profit (p.s.) 5.203
Sales Per Share 5.413
EBITDA (p.s.) 4.053
Qtrly Earnings Growth 1.90
Operating Cash Flow (M) 24
Levered Free Cash Flow (M) 18

Stock Valuations

PE Ratio 19.71
PEG Ratio
Price to Book value 3.74
Price to Sales 12.16
Price to Cash Flow 19.75

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.